Fig. 2From: MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAFV600E mutationPercentage of methylated reference as per [20] (Bettington et al. 2017), of BRAF mutant dysplastic sessile serrated adenomas (Left) and BRAF mutant colorectal cancers (Right) stratified for MLH1–93 genotype, and MLH1 protein immunostainingBack to article page